‘Overwhelming evidence’ FDA’s opioid approval process is shoddyOctober 1, 2020PainAddiction MedicineHealth Policy
New acute pain guidelines from the ACP and AAFP have limitationsSeptember 21, 2020PainMental HealthAddiction MedicineOrthopedics
Reworked OxyContin fails to cut overall opioid abuse, FDA panel saysSeptember 15, 2020Addiction MedicinePain
All NSAIDs raise post-MI risk but some are safer than others: Next chapterAugust 5, 2020CardiologyPain
